Huber Capital Management LLC Acquires 9,000 Shares of Tenet Healthcare Corporation $THC

Posted by Brenda Bartman on Jun 14th, 2026

Huber Capital Management LLC boosted its holdings in Tenet Healthcare Corporation (NYSE:THC – Free Report) by 17.5% during the 4th quarter, HoldingsChannel.com reports. The institutional investor owned 60,301 shares of the company’s stock after purchasing an additional 9,000 shares during the period. Tenet Healthcare accounts for approximately 1.8% of Huber Capital Management LLC’s portfolio, making the stock its 19th largest position. Huber Capital Management LLC’s holdings in Tenet Healthcare were worth $11,983,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also modified their holdings of THC. NewEdge Advisors LLC increased its position in shares of Tenet Healthcare by 6.1% during the first quarter. NewEdge Advisors LLC now owns 2,890 shares of the company’s stock valued at $389,000 after purchasing an additional 166 shares during the period. Jones Financial Companies Lllp increased its position in shares of Tenet Healthcare by 299.1% during the first quarter. Jones Financial Companies Lllp now owns 1,700 shares of the company’s stock valued at $229,000 after purchasing an additional 1,274 shares during the period. Sivia Capital Partners LLC bought a new stake in shares of Tenet Healthcare during the second quarter valued at approximately $290,000. Quantbot Technologies LP bought a new stake in shares of Tenet Healthcare during the second quarter valued at approximately $65,000. Finally, Amundi increased its position in shares of Tenet Healthcare by 4,207.8% during the second quarter. Amundi now owns 27,010 shares of the company’s stock valued at $4,652,000 after purchasing an additional 26,383 shares during the period. 95.44% of the stock is currently owned by institutional investors.

Insider Activity

In other Tenet Healthcare news, Director Nadja West sold 3,000 shares of the stock in a transaction dated Wednesday, May 27th. The stock was sold at an average price of $177.35, for a total value of $532,050.00. Following the transaction, the director owned 24,805 shares of the company’s stock, valued at approximately $4,399,166.75. This represents a 10.79% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, Director J Robert Kerrey sold 5,638 shares of the stock in a transaction dated Thursday, May 28th. The shares were sold at an average price of $174.52, for a total value of $983,943.76. Following the completion of the transaction, the director directly owned 16,804 shares in the company, valued at $2,932,634.08. The trade was a 25.12% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. 0.97% of the stock is owned by company insiders.

Tenet Healthcare Price Performance

Tenet Healthcare stock opened at $174.67 on Friday. The business’s 50-day simple moving average is $183.94 and its 200 day simple moving average is $199.94. The stock has a market cap of $15.05 billion, a price-to-earnings ratio of 9.08, a P/E/G ratio of 1.44 and a beta of 1.28. Tenet Healthcare Corporation has a 12-month low of $146.60 and a 12-month high of $247.21. The company has a quick ratio of 1.30, a current ratio of 1.36 and a debt-to-equity ratio of 1.96.

Tenet Healthcare (NYSE:THC – Get Free Report) last posted its quarterly earnings results on Thursday, April 30th. The company reported $4.82 earnings per share (EPS) for the quarter, beating the consensus estimate of $4.21 by $0.61. The business had revenue of $5.37 billion for the quarter, compared to analysts’ expectations of $5.39 billion. Tenet Healthcare had a return on equity of 25.55% and a net margin of 7.94%.The firm’s quarterly revenue was up 2.6% compared to the same quarter last year. During the same quarter last year, the business earned $4.36 earnings per share. Tenet Healthcare has set its FY 2026 guidance at 16.380-18.68 EPS. As a group, research analysts anticipate that Tenet Healthcare Corporation will post 17.61 earnings per share for the current year.

Analyst Upgrades and Downgrades

A number of analysts have weighed in on the company. Leerink Partners upped their price target on Tenet Healthcare from $255.00 to $264.00 and gave the company an “outperform” rating in a research report on Friday, February 20th. Truist Financial boosted their price objective on Tenet Healthcare from $240.00 to $270.00 and gave the stock a “buy” rating in a research note on Tuesday, February 17th. Wall Street Zen lowered Tenet Healthcare from a “strong-buy” rating to a “buy” rating in a research note on Monday, May 11th. Barclays reduced their price objective on Tenet Healthcare from $257.00 to $238.00 and set an “overweight” rating on the stock in a research note on Tuesday, May 5th. Finally, Morgan Stanley set a $254.00 price objective on Tenet Healthcare in a research note on Friday, May 1st. Eighteen equities research analysts have rated the stock with a Buy rating and four have assigned a Hold rating to the company’s stock. According to data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus price target of $244.16.

Check Out Our Latest Stock Analysis on Tenet Healthcare

About Tenet Healthcare

(Free Report)

Tenet Healthcare Corporation (NYSE: THC) is a diversified American healthcare services company that owns and operates acute care hospitals and a broad range of outpatient facilities. Its portfolio includes general acute-care hospitals, specialty hospitals, ambulatory surgery centers, urgent care and diagnostic imaging centers, and other ancillary service locations. Tenet’s operations are oriented around delivering inpatient and outpatient clinical care across multiple medical specialties, with an emphasis on surgical services, emergency care, and advanced diagnostics.

In addition to facility-based care, Tenet provides integrated services designed to support clinical operations and improve patient access and care coordination.